Trial Profile
An open-label study of Lamictal [lamotrigine] in neurotic excoriation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2019
Price :
$35
*
At a glance
- Drugs Lamotrigine (Primary)
- Indications Impulse control disorders
- Focus Therapeutic Use
- 15 Dec 2009 Actual patient number (25) added as reported by ClinicalTrials.gov.
- 08 Jan 2007 Status change
- 01 Nov 2006 New trial record.